reference/7105391

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/7105391

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Comparative Study\|Journal Article\|Multicenter Study\|Randomized Controlled Trial
endingPage	310
issn	1081-1206
issueIdentifier	3
pageRange	304-310
publicationName	Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
startingPage	304
bibliographicCitation	Frèche C, Leynadier F, Horak F, Hide D, Gracia FD, Goos M, Bachert C, Horvath A, Antosova E, Verrecchia M, Soussen PB. Mizolastine provides effective symptom relief in patients suffering from perennial allergic rhinitis: a double-blind, placebo-controlled study versus loratadine. Ann Allergy Asthma Immunol. 2002 Sep;89(3):304–10. doi: 10.1016/s1081-1206(10)61959-x. PMID: 12269652.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_80f6ce7bef9d96cc4711ac3328487714 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_60656c373da6fafbef092f5282898c1a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_558f5b59eef053eda696a2ab59cc465e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e7978c7a5473bdcb6a18a76fa294be04 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c83ffdd9cc133cc74c5823d29bb1c9ac http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_78c429c21f98604ecd5e3e0e27425a34 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3af18b12ea0c758f818030598677418e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3027d2fe8d7d0c8ca515bc5f8472f200 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_709b44a2f2f950ecd255bbea03ab3cb8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a193f2d2cd7d889f68c5ce0d2ffe656a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8db9ccab98852a0512659f281a2d2336
date	200209
identifier	https://pubmed.ncbi.nlm.nih.gov/12269652 https://doi.org/10.1016/s1081-1206%2810%2961959-x
isPartOf	https://portal.issn.org/resource/ISSN/1081-1206 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/8743
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Mizolastine provides effective symptom relief in patients suffering from perennial allergic rhinitis: a double-blind, placebo-controlled study versus loratadine
discusses	http://id.nlm.nih.gov/mesh/M0010395 http://id.nlm.nih.gov/mesh/M0028295 http://id.nlm.nih.gov/mesh/M0026329 http://id.nlm.nih.gov/mesh/M0204949 http://id.nlm.nih.gov/mesh/M0002348
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D006634Q000627 http://id.nlm.nih.gov/mesh/D001562Q000627 http://id.nlm.nih.gov/mesh/D018926Q000627 http://id.nlm.nih.gov/mesh/D012221Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000293 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D018926Q000009 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D006634Q000009 http://id.nlm.nih.gov/mesh/D012221Q000175 http://id.nlm.nih.gov/mesh/D004311 http://id.nlm.nih.gov/mesh/D001562Q000009 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D017336Q000627
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8995 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9742 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3957 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9112 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9562 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9255 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6764 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65906

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128253731 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128754351

Total number of triples: 59.